A Competing-Risk Nomogram Predicting Second Primary Malignancy in Hepatocellular Carcinoma Survivors
Xuqi Sun(Zhejiang University), MS Chen(Sun Yat-sen University), Jinbin Chen(Sun Yat-sen University), Juncheng Wang(Gansu Agricultural University), Li Xu(Fujian Medical University), Dandan Hu(Tongji University), Zhongguo Zhou(Sun Yat-sen University), Yaojun Zhang(Sun Yat-sen University)
Cited by 0
Related Papers
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma
|Therapeutic Advances in Medical Oncology|2021|216
The NAergic locus coeruleus-ventrolateral preoptic area neural circuit mediates rapid arousal from sleep
|Current Biology|2021|76
Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy
|Journal of Inflammation Research|2021|49
Recycling and direct regeneration of valuable cathode materials from spent Li-ion batteries: a comprehensive review
|Journal of Materials Chemistry A|2025|40